BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Accentia Biopharmaceuticals 

324 South Hyde Park Ave.
Suite 350
Tampa  Florida  33606  U.S.A.
Phone: 813-864-2554 Fax: 813-258-6912


SEARCH JOBS








 Company News
Accentia Biopharmaceuticals (ABPI), Biovest International, Inc. Shrink Losses, Default on Debt 12/27/2012 8:16:32 AM    More...
Accentia Biopharmaceuticals (ABPI) Conducts Investigator Meeting in Preparation for New Multiple Sclerosis Drug Study for Cyrevia™ 5/4/2012 10:05:40 AM    More...
Biovest International, Inc. to Seek Marketing Approval for BiovaxID® Personalized Lymphoma Cancer Vaccine in Canada 4/10/2012 10:04:42 AM    More...
Accentia Biopharmaceuticals (ABPI) Completes Sale of Analytica Group Subsidiary 12/20/2011 6:54:46 AM    More...
Accentia Biopharmaceuticals (ABPI) Has $10 Million Deal to Sell Analytica 11/7/2011 7:23:43 AM    More...
Accentia Biopharmaceuticals (ABPI) Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Prevention of Graft-Versus-Host Disease in Bone Marrow Transplant 9/14/2011 9:20:40 AM    More...
Accentia Biopharmaceuticals (ABPI) and Biovest International, Inc. to Present at Biotechnology Industry Organization (BIO) International Convention 6/24/2011 9:14:21 AM    More...
Accentia Biopharmaceuticals (ABPI) Announces that FDA Grants Orphan Drug Status for Revimmune(TM) Therapy for the Treatment of Two Autoimmune Diseases: Systemic Sclerosis & Hemolytic Anemia 6/23/2011 8:39:33 AM    More...
Accentia Biopharmaceuticals (ABPI) Announces that Revimmune(TM) Autoimmune Disease Therapy is Featured in Peer-review Journal 5/4/2011 11:28:05 AM    More...
Accentia Biopharmaceuticals (ABPI) Announces Strategic Agreement with Baxter Healthcare Corporation (BAX) 11/29/2010 9:59:25 AM    More...
12345678910

//-->